Market may have further to go on the downside

Bearish chart  The S & P 500 closed down 1.19% Monday on any number of growing anxieties.  We are oversold on a short-term basis but the RSI line is picking up momentum on the way down.  Not good.  Besides the 50 day moving average has been convincingly broken.  Interesting enough Berkshire Hathaway stock is now down for the year. It kind of looks like my broken position in Wells Fargo which is also one of BRK.A’s largest positions. The last year Buffett’s Berkshire Hathaway was negative and the S&p 500 had positive returns was 1999.   There was also massive Internet … Read more

Charlie Sheen Shorts Berkshire Hathaway. Proves you can still make a killing in the market while wasted.

The Sax Angle created a hypothetical portfolio for Charlie Sheen.  Our extensive backtesting proves you can still get wasted and make a killing in the stock market.

Charlie Sheen’s stock portfolio produced enormous gains while his career floundered.   That’s the conclusion that the analysts at the SAX  ANGLE came to while building a hypothetical portfolio of Charlie Sheen’s stock holdings.  Based on public information, TV shows, and extensive web gossip, we concluded that Charlie Sheen should own or control significant stock in nine companies, some private and public.

1. Playboy Enterprises PLA.A

Charlie Sheen should get involved in a group offering a rival bid to Hugh Hefner’s attempt to take Playboy (PLA) Enterprise private.  Once a sought out guest of the Playboy Mansion, Charlie should plan behind the scenes to throw out its namesake owner. Once his buyout group gets control of Playboy, we suggest that Charlie plan to move into the mansion and mummify Hef and display him wax figure like descending the entrance stairs.

2. Laboratory Holdings- LH

Sheen should work with the drug testing giant’s research lab to make drug tests anyone can pass.  Charlies should direct his agent to make a deal for him to be the spokesperson for the new “Easy Pass Come Clean Machine.”

3.  Betty Ford Clinic Buyout

Read more